x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

US floats idea of early approval for eventual vaccine

Health & Science - By AFP | August 31st 2020 at 08:15:11 GMT +0300

Clinical trials must wait to see if there is a significant difference in the infection rate of two groups, one given an experimental vaccine, the other a placebo. [AFP]

The head of the US Food and Drug Administration raised the possibility in an interview published Sunday that a future vaccine against the coronavirus might be given emergency approval before the end of trials designed to ensure its safety and effectiveness.

A request for such extraordinary approval would have to come from the vaccine developer, Stephen Hahn told the Financial Times.

"If they do that before the end of Phase Three," which involves large-scale human testing, "we may find that appropriate. We may find that inappropriate, we will make a determination.”

But Hahn insisted he was not acting under pressure from President Donald Trump, who has been pushing hard for a vaccine, saying one might be ready before US elections November 3.

Covid 19 Time Series

 

"This is going to be a science, medicine, data decision," Hahn said. "This is not going to be a political decision."

Three Western drugs makers are well along with their Phase 3 clinical trials, involving tens of thousands of participants.

The three are AstraZeneca, which is partnering with Oxford University in England; Moderna, collaborating with the US National Institutes of Health, and the Pfizer/BioNTech alliance.

By the nature of the trials it is difficult to predict when reliable results will emerge.

Half of the participants in such trials receive an experimental vaccine, while the other half are given a placebo.

Under normal procedures, test administrators must wait -- probably for months -- to see whether there is a statistically significant difference in the infection rate of the two groups.

As the world desperately awaits an effective vaccine against the deadly virus, China and Russia have already approved vaccines without waiting for the conclusion of trials -- drawing criticism from public health officials in other countries, including the US.

Hahn also said that an emergency authorization would not necessarily cover everyone -- it might be granted for specific, high-risk groups.

"Our emergency use authorization is not the same as a full approval," he said.

Hahn has faced mounting criticism from the medical community that he has given in to political pressure from the Trump administration, largely involving two incidents.

In March, the FDA gave emergency authorization for the use of hydroxychloroquine to treat Covid-19 after Trump repeatedly praised its use; the authorization had to be withdrawn in June after serious side effects emerged.

More recently, Hahn delivered a far too optimistic appraisal, during a news conference with Trump, of the effectiveness of convalescent plasma against the virus. He said it could save 35 out of 100 patients; the more likely number, experts said, is five in 100.

"It is f-ing outrageous to expedite *any* approval of a #SARSCoV2 vaccine, irrespective of @SteveFDA's subservience to Trump," Eric Topol, director of the Scripps Research Translational Institute, said on Twitter.

"We will not know about safety for many months."

Top Stories

Corona jab will be here by February, says PS
Health & Science - By Kagundu Njiru


Artificial melanin: New-age hair dye
Health & Science - By Killiad Sinide


My 21-year battle with HIV, cancer led me to become patient advocate
Health & Science - By Mercy Kahenda


Nurses sue to stop BBI drive, claim their proposals not captured
Health & Science - By Paul Ogemba


UK becomes first country to approve Pfizer Covid-19 vaccine
Health & Science - By Mercy Asamba


Doctors: Strike on next week
Health & Science - By Graham Kajilwa


Why Kenya is worst place to be as child with cancer
Health & Science - By Gatonye Gathura


Interpol warns that COVID-19 vaccines could be targeted by criminals
Health & Science - By Reuters


Now Kenya softens its stand on corona vaccine
Health & Science - By Graham Kajilwa


'A shot can end the stigma': African women pin hopes on anti-HIV jab
Health & Science - By Reuters


Latest Stories

My 21-year battle with HIV, cancer led me to become patient advocate
Health & Science - By Mercy Kahenda


Nurses sue to stop BBI drive, claim their proposals not captured
Health & Science - By Paul Ogemba


Doctors: Strike on next week
Health & Science - By Graham Kajilwa


Corona jab will be here by February, says PS
Health & Science - By Kagundu Njiru


US drugmaker Moderna to start testing Covid vaccine on children as young as 12
Health & Science - By Mirror


EU criticises 'hasty' UK approval of COVID-19 vaccine
Health & Science - By Reuters


Lab-grown meat goes on sale for first time
Health & Science - By Damian Carrington


Interpol warns that COVID-19 vaccines could be targeted by criminals
Health & Science - By Reuters


Calls for increased TB funding as cases rise
Health & Science - By Phares Mutembei


Pandemic affects HIV treatment goal
Health & Science - By Mercy Adhiambo


//

Stay Ahead!

Access premium content only available
to our subscribers.

Support independent journalism
×
Log in
Support independent journalism
Create an account    Forgot Password
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in